LumiraDx LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement The UK-based point-of-care diagnostics company received the letter because its common shares on the Nasdaq closed below $1 for 30 consecutive trading days. Earnings Roundup: OraSure Technologies, Standard BioTools, LumiraDx, More OraSure, Standard BioTools, LumiraDx, and Epigenomics reported their financial results this week. In Brief This Week: Applied DNA Sciences, LumiraDx, Lucid Diagnostics, Nanomix, Strata Oncology News items for the week of Aug. 15, 2022. In Brief This Week: LumiraDx, Natera, Caris Life Sciences News items for the week of July 18, 2022 LumiraDx to Publicly Offer 40M Shares The net proceeds will be used for general corporate purposes, including working capital for research and development. Jun 8, 2022 LumiraDx Gets CE Marks for SARS-CoV-2 Test, COVID-19-Flu Assay May 12, 2022 LumiraDx Q1 Revenues up 18 Percent Apr 6, 2022 As COVID-19 Sales Retreat, Diagnostic Firms Turn Attention to Core Businesses Premium Mar 10, 2022 LumiraDx Q4 Revenues Rise 5 Percent on SARS-CoV-2 Test Sales Feb 25, 2022 In Brief This Week: Labcorp, Personal Genome Diagnostics, Applied DNA Sciences, Cytek, More Dec 15, 2021 LumiraDx Inks Deal with Audere for At-Home COVID-19 Test Collection Kit Nov 15, 2021 Evercore ISI Initiates Coverage of LumiraDx With Outperform Rating Nov 10, 2021 LumiraDx Posts Strong Q3 Revenue Gains on Sales of SARS-CoV-2 Testing Products Oct 27, 2021 BTIG Initiates Coverage of LumiraDx With Buy Rating Aug 23, 2021 LumiraDx, CA Healthcare Acquisition Revise Merger Terms to Lower Equity Value of Combined Company Aug 4, 2021 Thermo Fisher Scientific, Access Bio, LumiraDx Get FDA EUAs for SARS-CoV-2 Tests Jul 1, 2021 LumiraDx Gets CE Mark for Molecular SARS-CoV-2 Test Apr 7, 2021 LumiraDx to Go Public on Nasdaq Through SPAC Oct 19, 2020 LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.